# UFP Technologies Inc: filings

UFPT · Nasdaq · CIK 914156 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ufpt.md) · [Financials](/companies/ufpt/financials.md) · [Filings](/companies/ufpt/filings.md) · [Insiders](/companies/ufpt/insiders.md)

## Reports and events: 265 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 628, 8-K 165, SC 13G/A 74, 10-Q 53, SC 13G 33, 144 30, 10-K 18, DEF 14A 18, 4/A 13, SD 13, 3 10, ARS 10, SCHEDULE 13G/A 6, UPLOAD 6, SC 13D/A 4, CORRESP 3, S-8 POS 3, SC 13D 3, SCHEDULE 13G 3, 144/A 2, 8-K/A 2, DEFR14A 2, PRE 14A 2, S-8 2, 10-K/A 1, 10-Q/A 1, 5 1, 8-A12B 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-24 | 14:09 ET | [8-K](/filings/0001628280-26-058536.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-058536 |
| 2026-08-06 | 20:50 ET | [10-Q](/filings/0001628280-26-054428.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054428 |
| 2026-08-03 | 20:12 ET | [8-K](/filings/0001628280-26-051846.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051846 |
| 2026-06-10 | 20:02 ET | [8-K](/filings/0001628280-26-042165.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-042165 |
| 2026-06-08 | 20:44 ET | [8-K](/filings/0001628280-26-041647.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-041647 |
| 2026-06-05 | 16:37 ET | [8-K](/filings/0001628280-26-041108.md) | 5.07 Shareholder vote results | 0001628280-26-041108 |
| 2026-05-26 | 20:17 ET | [8-K](/filings/0001628280-26-038097.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-038097 |
| 2026-05-08 | 20:03 ET | [10-Q](/filings/0001628280-26-032825.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032825 |
| 2026-05-04 | 20:56 ET | [8-K](/filings/0001628280-26-029906.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-029906 |
| 2026-04-30 | 16:40 ET | [DEF 14A](/filings/0001628280-26-028710.md) | Proxy statement, period 2026-06-04 | 0001628280-26-028710 |
| 2026-02-27 | 21:13 ET | [10-K](/filings/0001628280-26-012816.md) | Annual report, period 2025-12-31 | 0001628280-26-012816 |
| 2026-02-27 | 18:05 ET | [8-K](/filings/0001628280-26-012667.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-012667 |
| 2026-02-24 | 21:41 ET | [8-K](/filings/0001628280-26-011154.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-011154 |
| 2026-02-24 | 21:40 ET | [8-K](/filings/0001628280-26-011152.md) | 1.05 Material cybersecurity incident | 0001628280-26-011152 |
| 2026-02-24 | 21:39 ET | [8-K](/filings/0001628280-26-011150.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011150 |
| 2026-02-13 | 21:56 ET | [8-K](/filings/0001628280-26-008183.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-008183 |
| 2025-12-02 | 13:31 ET | [8-K](/filings/0001628280-25-054605.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-054605 |
| 2025-12-02 | 13:27 ET | [8-K](/filings/0001628280-25-054603.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-054603 |
| 2025-11-07 | 12:55 ET | [10-Q](/filings/0001628280-25-050425.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050425 |
| 2025-11-03 | 21:16 ET | [8-K](/filings/0001628280-25-048260.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048260 |
| 2025-08-21 | 20:16 ET | [8-K](/filings/0001171843-25-005547.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-005547 |
| 2025-08-11 | 12:31 ET | [10-Q](/filings/0001171843-25-005268.md) | Quarterly report, period 2025-06-30 | 0001171843-25-005268 |
| 2025-08-05 | 12:15 ET | [8-K](/filings/0001171843-25-005027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005027 |
| 2025-07-17 | 14:22 ET | [8-K](/filings/0001171843-25-004519.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004519 |
| 2025-06-10 | 12:59 ET | [8-K](/filings/0001171843-25-003809.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-003809 |
| 2025-06-06 | 14:45 ET | [8-K](/filings/0001171843-25-003753.md) | 5.07 Shareholder vote results | 0001171843-25-003753 |
| 2025-05-12 | 12:31 ET | [10-Q](/filings/0001171843-25-003049.md) | Quarterly report, period 2025-03-31 | 0001171843-25-003049 |
| 2025-05-07 | 12:39 ET | [8-K](/filings/0001171843-25-002859.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002859 |
| 2025-04-30 | 16:05 ET | [DEF 14A](/filings/0001171843-25-002638.md) | Proxy statement, period 2025-06-04 | 0001171843-25-002638 |
| 2025-04-04 | 20:05 ET | [8-K](/filings/0001171843-25-002025.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-25-002025 |
| 2025-03-20 | 20:02 ET | [8-K](/filings/0001171843-25-001597.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-001597 |
| 2025-03-03 | 14:37 ET | [10-K](/filings/0001171843-25-001192.md) | Annual report, period 2024-12-31 | 0001171843-25-001192 |
| 2025-02-25 | 21:10 ET | [8-K](/filings/0001171843-25-001061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001061 |
| 2025-02-18 | 21:33 ET | [8-K](/filings/0001171843-25-000897.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-000897 |
| 2024-11-12 | 18:42 ET | [8-K](/filings/0001171843-24-006275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006275 |
| 2024-11-12 | 13:48 ET | [10-Q](/filings/0001171843-24-006257.md) | Quarterly report, period 2024-09-30 | 0001171843-24-006257 |
| 2024-08-26 | 20:15 ET | [8-K](/filings/0001171843-24-004926.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-004926 |
| 2024-08-26 | 15:11 ET | [8-K](/filings/0001171843-24-004922.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-004922 |
| 2024-08-09 | 13:00 ET | [10-Q](/filings/0001171843-24-004633.md) | Quarterly report, period 2024-06-30 | 0001171843-24-004633 |
| 2024-08-02 | 20:15 ET | [8-K](/filings/0001171843-24-004404.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004404 |
| 2024-07-16 | 20:15 ET | [8-K](/filings/0001171843-24-003980.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-003980 |
| 2024-07-01 | 15:38 ET | [8-K](/filings/0001171843-24-003738.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-003738 |
| 2024-06-11 | 13:00 ET | [8-K](/filings/0001171843-24-003384.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-003384 |
| 2024-06-07 | 20:15 ET | [8-K](/filings/0001171843-24-003340.md) | 5.07 Shareholder vote results | 0001171843-24-003340 |
| 2024-05-10 | 12:45 ET | [10-Q](/filings/0001171843-24-002737.md) | Quarterly report, period 2024-03-31 | 0001171843-24-002737 |
| 2024-05-01 | 20:15 ET | [8-K](/filings/0001171843-24-002424.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002424 |
| 2024-04-26 | 20:17 ET | [DEF 14A](/filings/0001171843-24-002290.md) | Proxy statement, period 2024-06-05 | 0001171843-24-002290 |
| 2024-03-18 | 20:58 ET | [8-K](/filings/0001171843-24-001413.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-24-001413 |
| 2024-02-29 | 14:38 ET | [10-K](/filings/0001171843-24-001078.md) | Annual report, period 2023-12-31 | 0001171843-24-001078 |
| 2024-02-26 | 14:00 ET | [8-K](/filings/0001171843-24-000970.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-000970 |

Page 1 of 6. [Older](/companies/ufpt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.